The NovaSeq X and NovaSeq X Plus systems were purpose-designed to be our most sustainable sequencing systems with reductions in packaging weight and waste, maximizing storage space and saving on ...
Hosted on MSN1mon
Illumina targets high single-digit revenue growth by 2027 amid NovaSeq X transitionHe noted significant advancements in operational excellence, customer collaboration, and innovation, including the NovaSeq X transition and new partnerships. Illumina reported Q4 revenue of $1.1 ...
NovaSeq 6000 Sequencing System is designed to adapt to your needs so groundbreaking discoveries are always within reach. It's flexible, scalable science on your terms. NovaSeq 6000 offers deeper ...
Illumina's NovaSeq 6000 stands as the latest breakthrough in ultra-high throughput NGS sequencing instrumentation. This dual flow cell instrument is meticulously designed to function with four ...
The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...
In recent quarters, Illumina has focused on expanding its sequencing platforms and broadening application usages. Emphasis has been placed on customer adoption of its NovaSeq X platform ...
Hosted on MSN1mon
Earnings call transcript: Illumina Q4 2024 beats EPS, stock fallsThe company launched several new products, including the NovaSeq X series. Illumina is focusing on expansion in multiomics and data services. Illumina's performance in Q4 2024 showed modest growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results